Compare Oklo Inc (OKLO) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oklo Inc vs Tempus AI — how do they compare? Oklo Inc trades at $35.27 (market cap $6.85B), while Tempus AI trades at $70.29 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oklo Inc for 31 Days and Tempus AI for 22 Days on average.
| OKLO | TEM | |
|---|---|---|
Market Cap | $6.85B | $12.58B |
Volume | 11,387,867 | 7,444,569 |
Sector | Utilities | Broad Market / Factor |
52-Week High | $174.14 | $99.28 |
52-Week Low | $34.57 | $41.55 |
Typical Hold Time | 31 Days | 22 Days |
Enterprise Value | $4.39B | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $36.82, down 4.49% on the day, with bearish technical indicators showing resistance at $37-38. The company shows no revenue in 2025 and negative net income of -$105.66M, though analyst consensus remains strongly bullish with a $78.63 price target. Recent news highlights nuclear energy sector momentum but notes OKLO's early commercialization stage and recent $1 billion stock sale.
Outlook hinges on project pipeline execution amid substantial cash burn. High institutional support via financing ($1.26B in 2025) fuels growth bets, but profitability remains distant with a -12,625.54% net margin. Risks include dilution from equity raises and intense SMR competition. The stock offers speculative upside if contracts materialize but carries high volatility.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
